Cremisi Henry D. 4
4 · DAXOR CORP · Filed Jul 9, 2020
Insider Transaction Report
Form 4
DAXOR CORPDXR
Cremisi Henry D.
Director
Transactions
- Award
STOCK OPTION (right to buy)
2020-06-25+18,000→ 18,000 totalExercise: $13.94From: 2020-06-25Exp: 2025-06-04→ COMMON STOCK (18,000 underlying) - Award
STOCK OPTION (right to buy)
2020-06-25+2,000→ 2,000 totalExercise: $13.48Exp: 2025-06-25→ COMMON STOCK (2,000 underlying)
Footnotes (2)
- [F1]Stock options were granted June 4, 2020 contingent upon the approval by Daxor Corporation shareholders of the Daxor Corporation 2020 Incentive Compensation plan (the "Plan") at the 2020 annual meeting of shareholders held on June 25, 2020. The plan was approved by the Daxor Corporation shareholders.
- [F2]The stock options will vest in three installments June 25, 2021 (667) June 25, 2022 (667) and June 25, 2023 (666)